This study is looking at how two different medications, Remimazolam and Midazolam, affect your thinking and memory after cataract surgery. Both medications are given to help you relax during surgery. Researchers want to see if one of these medications leads to fewer changes in your thinking and memory right after surgery and the next day. They will measure this using a test called the Montreal Cognitive Assessment (MoCA). You could be eligible if you are 65 or older, having your first eye cataract surgery, and meet certain health criteria. The study aims to enroll 120 participants. The current status of this study is unclear.

Study design

This study is an interventional study, meaning participants will receive a specific treatment. You will be randomly assigned to receive either Remimazolam or Midazolam during your cataract surgery.

What's involved

You will complete a MoCA test before surgery, after surgery in the recovery room, and again the next day during your follow-up visit. You will also rate your satisfaction with your anesthesia.

Compensation

Not stated in the trial record.

Follow-up

You will be in this study from the day of surgery until your first post-operative visit, which is the following day.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.